Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Autor:	Riccardo Bomben, Chris Pepper, Zarni Soe, Kevin Norris, David Allsup, Jerry Polesel, Christopher Fegan, Pei Loo Ow, Andy C. Rawstron, Daniel Catovsky, Anna Hockaday, Antonella Zucchetto, Andrea Pepper, Peter Hillmen, Pietro Bulian, Erika Tissino, Duncan M. Baird, Valter Gattei
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	Oncology Cancer Research medicine.medical_specialty Chronic lymphocytic leukaemia Letter Integrin alpha4 Immunoglobulin Variable Region CD49d Text mining Internal medicine Antineoplastic Combined Chemotherapy Protocols Biomarkers Tumor Medicine Humans Cyclophosphamide business.industry Wild type Telomere Homeostasis Hematology Translational research Prognosis Leukemia Lymphocytic Chronic B-Cell Telomere Term (time) Survival Rate Mutation Neoplasm Recurrence Local Tumor Suppressor Protein p53 business IGHV@ Immunoglobulin Heavy Chains Rituximab Vidarabine Follow-Up Studies
Zdroj:	Leukemia
ISSN:	0887-6924
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef924c15eb918bddabc57a7425d7c7e http://sro.sussex.ac.uk/id/eprint/100090/1/s41375-021-01322-1.pdf Zobrazit plný text záznamu Full text from SpringerLink